Quantitative correlations among CYP3A sensitive substrates and inhibitors: Literature analysis

Current Drug Metabolism

Volumn 8, Issue 8, 2007, Pages 810-814

  Ragueneau Majlessi, Isabelle ^a   Boulenc, Xavier ^b   Rauch, Clemence ^b   Hachad, Houda ^a   Levy, René H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SANOFI   (France)

Author keywords

Cytochrome P450 CYP3A; Drug drug interactions; Inhibition

Indexed keywords

BUSPIRONE; CYTOCHROME P450 3A; DILTIAZEM; EPLERENONE; ERYTHROMYCIN; FLUCONAZOLE; KETOCONAZOLE; MIDAZOLAM; SIMVASTATIN; TRIAZOLAM; VERAPAMIL;

AREA UNDER THE CURVE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CLEARANCE; DRUG METABOLISM; DRUG POTENCY; DRUG RESEARCH; DRUG SENSITIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; LINEAR REGRESSION ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; STATISTICAL MODEL;

CYTOCHROME P-450 CYP3A; DATABASES, FACTUAL; DRUG INTERACTIONS; ENZYME INHIBITORS; ERYTHROMYCIN; FLUCONAZOLE; KETOCONAZOLE; MIDAZOLAM; SUBSTRATE SPECIFICITY; VERAPAMIL;

EID: 36949032109     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920007782798135     Document Type: Review

References (26)

1. Dept. of Health and Human Services (US), Food and Drug Administration, Center for Drug Evaluation and Research, and Center for Biologics Evaluation and Research. Draft guidance for industry: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling. September 2006.
2. Masica, A.L.; Mayo, G. and Wilkinson, G.R. (2004) Clin. Pharmacol. Ther. 76(4), 341-349.
3. Galetin, A.; Ito, K.; Hallifax, D. snd Houston, J.B. (2005) J. Pharmacol. Exp. Ther. 314(1), 180-190.
4. Benet, L.Z (2005) Mol. Interv. 5(2), 79-83.
5. Kharasch, E.D.; Thummel, K.E. and Watkins, P.B. (2005) Mol. Interv. 5(3), 151-153.
6. Robertson, S.M.; Formentini, E.; Alfaro, R.M.; Falloon, J. and Penzak, S.R. (2006) Pharmacotheerapy, 26(8), 1051-1059.
7. Chung, E.; Nafziger, A.N. Kazieiad, D.J. and Bertino, J.S., Jr. (2006) Clin. Pharmacol. Ther. 79(4), 350-361.
8. Grub, S.; Bryson, H.; Goggin, T.; Ludin, E. and Jorga, K. (2001) Eur. J. Clin. Pharmacol. 57(2), 115-121.
9. Invirase [prescribing information]. Nutley, NJ: Roche Pharmaceuticals; 2005.
10. Warot, D.; Bergougnan, L.; Lamiable, D.; Berlin, I.; Bensimon, G.; Danjou, P. and Puech, A.J. (1987) Eur. J. Clin. Pharmacol. 32(4), 389-393.
11. Barbhaiya, R.H.; Shukla, U.A.; Kroboth, P.D. and Greene, D.S. (1995) J. Clin. Psychopharmacol. 15(6), 320-326.
12. de Mey, C.; Althaus, M.; Ezan, E. and Retzow, A. (2001) Clin. Pharmacol. Ther. 70(2), 142-148.
13. Kivisto, K.T.; Lamberg, T.S.; Kantola T. and Neuvonen, P.J. (1997) Clin. Pharmacol. Ther. 62(3), 348-354.
14. Kantola, T.; Kivisto, K.T. and Neuvonen, P.J. (1998) Clin. Pharmacol. Ther. 64(2), 177-182.
15. Grub, S.; Bryson, H.; Goggin, T.; Ludin, E. and Jorga, K. (2001) Eur. J. Clin. Pharmacol. 57(2), 115-121.
16. Lamberg, T.S.; Kivisto, K.T. and Neuvonen, P.J. (1998) Clin. Pharmacol. Ther. 63(6), 640-645.
17. Koks, C.H.; Crommentuyn, K.M.; Hoetelmans, R.M.; Burger, D.M.; Koopmans, P.P.; Mathot, R.A. Mulder, J.W.; Meenhorst, P.L. and Beijnen, J.H. (2001) Br. J. Clin. Pharmacol. 51(6), 631-635.
18. Obach, R.S.; Walsky, R.L.; Venkatakrishnan, K.; Gaman, E.A.; Houston, J.B. and Tremaine, L.M. (2006) J. Pharmacol. Exp. Ther. 316(1), 336-348.
19. Galetin, A.; Burt, H.; Gibbons, L. and Houston, J.B. (2006) Drug Metab. Dispos. 34(1), 166-175.
20. Wang, Y.H.; Jones, D.R. and Hall, S.D. (2004) Drug Metab. Dispos. 32(2), 259-266.
21. Olkkola, K.T.; Backman, J.T. and Neuvonen, P.J. (1994) Clin. Pharmacol. Ther. 55(5), 481-485.
22. Wrighton, S.A. and Ring, Bd. (1994) Pharm. Res. 11(6), 921-924.
23. Iliopoulou, A.; Aldhous, M.E.; Johnston, A. and Turner, P. (1982) Br. J. Clin. Pharmacol. 14(4), 495-499.
24. Kharasch, E.D.; Walker, A.; Hoffer. C. and Sheffels, P. (2004) Clin. Pharmacol. Ther. 76(5), 452-466.
25. Levy, R.H.; Hachad, H.; Yao, C. and Ragueneau-Majlessi, I. (2003) Curr. Drug Metab. 4(5), 371-380.
26. Wang, E.J.; Lew, K.; Casciano, C.N.; Clement; R.P. and Johnson, W.W. (2002) Antimicrob. Agents Chemother. 46(1), 160-165.